Platelets, a reliable source for peripheral Alzheimer’s disease biomarkers?
Open Access
- 16 June 2014
- journal article
- review article
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 2 (1) , 65
Abstract
Peripheral biomarkers play an indispensable role in quick and reliable diagnoses of any kind of disease. With the population ageing, the number of people suffering from age-related diseases is expected to rise dramatically over the coming decades. In particular, all types of cognitive deficits, such as Alzheimer’s disease, will increase. Alzheimer’s disease is characterised mainly by coexistence of amyloid plaques and neurofibrillary tangles in brain. Reliable identification of such molecular characteristics antemortem, however, is problematic due to restricted availability of appropriate sample material and definitive diagnosis is only possible postmortem. Currently, the best molecular biomarkers available for antemortem diagnosis originate from cerebrospinal fluid. Though, this is not convenient for routine diagnosis because of the required invasive lumbar puncture. As a consequence, there is a growing demand for additional peripheral biomarkers in a more readily accessible sample material. Blood platelets, due to shared biochemical properties with neurons, can constitute an attractive alternative as discussed here. This review summarises potential platelet Alzheimer’s disease biomarkers, their role, implication, and alteration in the disease. For easy comparison of their performance, the Hedge effect size was calculated whenever data were available.Keywords
This publication has 208 references indexed in Scilit:
- Glycogen synthase kinase‐3β (GSK3β) expression in a mouse model of Alzheimer's disease: A light and electron microscopy studySynapse, 2013
- Inhibition of phospholipase A2 in rat brain modifies different membrane fluidity parameters in opposite waysProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- Monoamine oxidase inactivation: From pathophysiology to therapeuticsAdvanced Drug Delivery Reviews, 2008
- What’s new in using platelet research? To unravel thrombopathies and other human disordersEuropean Journal of Pediatrics, 2007
- Impaired platelet mitochondrial activity in Alzheimer’s disease and mild cognitive impairmentMitochondrion, 2006
- Cholesterol, a modulator of membrane-associated aβ-fibrillogenesis and neurotoxicityJournal of Molecular Biology, 2001
- Cl−-ATPase and Na+/K+-ATPase activities in Alzheimer's disease brainsNeuroscience Letters, 1998
- Phospholipase A2 Activation Influences the Processing and Secretion of the Amyloid Precursor ProteinBiochemical and Biophysical Research Communications, 1993
- Concurrence of cortex and platelet serotonin2 receptor binding characteristics in the individual and the putative regulation by serotoninJournal of Neural Transmission, 1993
- Human brain cortex and platelet serotonin2 receptor binding properties and their regulation by endogenous serotoninLife Sciences, 1993